Connection

Contact Us
If you have any questions or feedback please contact us.

Search Results to Mark Boguniewicz

This is a "connection" page, showing the details of why an item matched the keywords from your search.

Search Results

Boguniewicz, Mark

One or more keywords matched the following items that are connected to Boguniewicz, Mark

Item Type	Name
Academic Article	Advances in allergic skin diseases.
Academic Article	A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children. Pediatric Tacrolimus Study Group.
Academic Article	Treatment options and new therapeutic approaches in atopic dermatitis.
Academic Article	Tacrolimus ointment 0.03% shows efficacy and safety in pediatric and adult patients with mild to moderate atopic dermatitis.
Academic Article	Tacrolimus ointment 0.03% is safe and effective for the treatment of mild to moderate atopic dermatitis in pediatric patients: results from a randomized, double-blind, vehicle-controlled study.
Academic Article	Sustained efficacy and safety of pimecrolimus cream 1% when used long-term (up to 26 weeks) to treat children with atopic dermatitis.
Academic Article	An approach to pruritus in atopic dermatitis: a critical systematic review of the tacrolimus ointment literature.
Academic Article	Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents.
Academic Article	Cost-effectiveness analysis of tacrolimus ointment versus high-potency topical corticosteroids in adults with moderate to severe atopic dermatitis.
Academic Article	1% pimecrolimus cream for atopic dermatitis.
Academic Article	Report of the Topical Calcineurin Inhibitor Task Force of the American College of Allergy, Asthma and Immunology and the American Academy of Allergy, Asthma and Immunology.
Academic Article	A multiple-domain framework of clinical, economic, and patient-reported outcomes for evaluating benefits of intervention in atopic dermatitis.
Concept	Immunosuppressive Agents
Academic Article	Expert Perspectives on Management of Moderate-to-Severe Atopic Dermatitis: A Multidisciplinary Consensus Addressing Current and Emerging Therapies.
Academic Article	Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE- and Institute of Medicine-based recommendations.

Search Criteria

Immunosuppressive Agents